Global biopharmaceutical company AstraZeneca signed an agreement to transfer the company’s office headquarters in Israel to the O-TECH complex in Kfar Saba.AstraZeneca will lease 1,245 sq.m. in Building B in the O-TECH complex.AstraZeneca is a leading firm in science and the development of innovative prescription drugs, and is one of the world’s leading companies in the development of the coronavirus vaccine. console.log("catid body is "+catID);if(catID==120){document.getElementsByClassName("divConnatix")[0].style.display ="none";var script = document.createElement('script'); script.src = 'https://player.anyclip.com/anyclip-widget/lre-widget/prod/v1/src/lre.js'; script.setAttribute('pubname','jpostcom'); script.setAttribute('widgetname','0011r00001lcD1i_12258'); document.getElementsByClassName('divAnyClip')[0].appendChild(script);}else if(catID!=69 && catID!=2){ document.getElementsByClassName("divConnatix")[0].style.display ="none"; var script = document.createElement('script'); script.src = 'https://static.vidazoo.com/basev/vwpt.js'; script.setAttribute('data-widget-id','60fd6becf6393400049e6535'); document.getElementsByClassName('divVidazoo')[0].appendChild(script); }In 2019, it signed a memorandum of understanding with the Israel Innovation Authority, and pledged to invest in and support the health ecosystem in Israel.The O-TECH project is a new complex for hi-tech, biotech and international companies, which includes three office buildings, a recreation, entertainment and catering center with an area of more than 100,000 sq.m. The value of the project is approximately NIS 800 million.Aviv Cohen, CEO of Oshira – the company that established the O-TECH complex – said: “It is with great pride that the largest company in the UK in the field of pharmaceuticals is joining the O-TECH complex.”The agreement is the fifth O-TECH signed during the coronavirus crisis, and negotiations are underway to sign two more agreements.
